As part of Cheddar's Crypto Craze series we dive into the latest news in this evolving space, and trends impacting the markets. In this episode Cheddar's Hope King and Brad Smith explore how the major cryptocurrencies are performing, and why some researchers are bullish on Bitcoin. Plus, how regulators are looking to crack down on this space.
It was a relatively flat week for the three major cryptocurrencies Bitcoin, Ethereum, and Ripple's XRP. Canaccord Genuity Managing Director Michael Graham explains the latest trends in the market and his outlook for the year ahead.
Graham cites increased regulation in South Korea and China as driving prices down from all-time highs. "For the last couple week's we've been sort-of recovering from all that," explains Graham.
Entrepreneur and Choose Yourself Financial Founder James Altucher has a bold prediction for Bitcoin. Altucher predicts Bitcoin could reach between $100,000 to $300,000 by the end of 2018. He explains the argument for his bullish stance on this cryptocurrency, and addresses promises he is making to his subscribers.
Altucher defended his business strategy to lure subscribers with flashy commercials. Altucher says that his investment return guarantee newsletter is a strategy to educate the masses on Bitcoin.
"I'm a big believer that people need to be educated on what Bitcoin and cryptocurrencies are, and the effect they are going to have on society," said Altucher.
Smoke that filled the cabin of a Delta flight as it took off from the Atlanta airport in February was so thick the led flight attendant had trouble seeing past the first row of passengers and the pilots donned oxygen masks as a precaution.
Arjan Stephens, President of Nature's Path, discusses the company's origin, how it has evolved today and the interesting product that came from his wedding!
Small business reporter, Gene Marks, joins Cheddar to give analysis on how small businesses are tackling incoming tariffs and how it will affect the consumer.
Babylist CEO Natalie Gordon joins Cheddar to discuss how the website is helping new parents, how to make a registry and how secondhand options are available.
Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection.
